Testing the Timing: Time Factor in Radiation Treatment for Head and Neck Cancers
- PMID: 29527638
- DOI: 10.1007/s11864-018-0534-0
Testing the Timing: Time Factor in Radiation Treatment for Head and Neck Cancers
Abstract
Overall radiation treatment time has long been recognized as an important factor in head and neck tumor control. The concern of tumor growth in waiting time either before starting radiotherapy or during treatment is substantial given its negative impact on clinical outcome. There is an overwhelming evidence that increasing the time to initiate treatment increases the tumor burden and worsens the prognosis. This effect is more pronounced especially in patients with an early stage cancer disease. Delay in treatment initiation is contributed by both health care- and patient-related factors. Health care-related factors include advancement in diagnostic modalities and transfer of patient to academic health care centers accompanied by delayed referrals and long-awaited appointments. Patient-related factors include delayed reporting time and socioeconomic factors. An efficient transition of care along with access of cancer care modalities to community health care centers will not only improve the quality of care in secondary health care centers but also help decrease the patient burden in tertiary centers. A quick and well-structured multidisciplinary appointment program is fundamental in shortening the time required for patient referrals, thus increasing the optimal survival time for Head and Neck cancer patients with early initiation of treatment.
Keywords: Head and neck cancers; Radiation therapy; Radiation treatment time; Time to treatment initiation; Treatment package time.
Similar articles
-
Disparities in head and neck cancer: assessing delay in treatment initiation.Laryngoscope. 2012 Aug;122(8):1756-60. doi: 10.1002/lary.23357. Epub 2012 May 8. Laryngoscope. 2012. PMID: 22570084
-
Is there any significant reduction of patients' outcome following delay in commencing postoperative radiotherapy?Curr Opin Otolaryngol Head Neck Surg. 2006 Apr;14(2):82-4. doi: 10.1097/01.moo.0000193177.62074.fd. Curr Opin Otolaryngol Head Neck Surg. 2006. PMID: 16552263 Review.
-
Cost-Effectiveness of Reduced Waiting Time for Head and Neck Cancer Patients due to a Lean Process Redesign.Value Health. 2015 Jul;18(5):587-96. doi: 10.1016/j.jval.2015.04.003. Epub 2015 Jun 10. Value Health. 2015. PMID: 26297086
-
What are the real waiting times for therapeutic management of head and neck cancer: a study in the general population in the north-west of France.Eur Arch Otorhinolaryngol. 2016 Nov;273(11):3951-3958. doi: 10.1007/s00405-016-4056-8. Epub 2016 Apr 27. Eur Arch Otorhinolaryngol. 2016. PMID: 27119321
-
Radiation treatment breaks and ulcerative mucositis in head and neck cancer.Oncologist. 2008 Aug;13(8):886-98. doi: 10.1634/theoncologist.2008-0024. Epub 2008 Aug 13. Oncologist. 2008. PMID: 18701763 Review.
Cited by
-
Association between treatment package time and clinical predictors in oropharyngeal cancer.Medicine (Baltimore). 2020 Sep 25;99(39):e22244. doi: 10.1097/MD.0000000000022244. Medicine (Baltimore). 2020. PMID: 32991419 Free PMC article.
-
Racial and Treatment Center Differences on Time to Treatment Initiation for Nonsmall Cell Lung Cancer Patients Receiving Radiation Therapy As an Initial Treatment.Health Equity. 2022 Aug 18;6(1):603-609. doi: 10.1089/heq.2022.0104. eCollection 2022. Health Equity. 2022. PMID: 36081886 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical